Patents by Inventor Tona Morgan Gilmer

Tona Morgan Gilmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination
    Publication number: 20170065593
    Abstract: A novel combination comprising the MEK inhibitor N-{3-[3- cyclopropyl- 5- (2- fluoro- 4- iodo- phenylamino)6,8- dimethyl;- 2,4,7-trioxo- 3,4,6,7- tetrahydro- 2H- pyrido[4,3- d]pyrimidin- 1- yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mTOR inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of MEK and/or mTOR is beneficial, e.g. cancer.
    Type: Application
    Filed: November 16, 2016
    Publication date: March 9, 2017
    Inventors: Tona Morgan Gilmer, Rakesh Kumar, Sylvie Laquerre
  • Cancer Treatment Method
    Publication number: 20100063074
    Abstract: The present invention relates to a method of treating cancer in a mammal by administration of 4-quinazolinamines and pharmaceutical compositions containing the same. In particular, the method relates to a methods of treating cancers which are mediated by the tyrosine kinases EGFR and/or erbB2 by administration of N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine and salts and solvates thereof.
    Type: Application
    Filed: June 1, 2005
    Publication date: March 11, 2010
    Inventors: Mark S. Berger, Tona Morgan Gilmer, Arundathy Nirmalini Pandite, David Rusnak, Neil L. Spector, Iman El-Hariry
  • CANCER TREATMENT METHOD
    Publication number: 20090317383
    Abstract: The present invention relates to a method of treating cancer in a mammal by administration of 4-quinazolinamines and at least one additional anti-neoplastic compound. In particular, the method relates to a methods of treating cancers by administration of N-{3-chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl) ethyl]amino} methyl)-2-furyl]-4-quinazolinamine and salts and solvates thereof in combination with at least one additional anti-neoplastic compound.
    Type: Application
    Filed: June 3, 2005
    Publication date: December 24, 2009
    Inventors: Mark S. Berger, Tona Morgan Gilmer, Arundathy Nirmalini Pandite
  • CANCER TREATMENT METHOD
    Publication number: 20090203718
    Abstract: The present invention relates to a method of treating cancer in a mammal and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering an erb family inhibitor and an IGF-1R inhibitor to a mammal suffering from a cancer.
    Type: Application
    Filed: April 13, 2006
    Publication date: August 13, 2009
    Applicant: SmithKline Beecham (Cork) Ltd.
    Inventors: David Rusnak, Tona Morgan Gilmer